A randomised, double-blind, placebo-controlled, dose ascending crossover study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of inhaled GSK159797 delivered by dry powder inhaler in mild to moderate asthmatic subjects.
Phase of Trial: Phase I/II
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Milveterol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 29 Sep 2006 New trial record.